SAN DIEGO--(BUSINESS WIRE)--Dec. 16, 2005--Aethlon Medical, Inc., (OTCBB:AEMD): -- Gives interim update of first human safety study of its Hemopurifier(TM) -- Announces the CDC has initiated testing of Aethlon’s technology as a potential treatment against the Ebola virus -- Discusses the continued enhancement of its leadership team Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, announced that its Chairman and CEO, James A. Joyce presented a company update yesterday at The New York Society of Security Analysts 9th Annual Biotech/Specialty Pharma Conference.
